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PreviewsGetting RIP’d Stunts Your Growth
The p75 neurotrophin receptor (p75NTR) collaborates
with the Nogo receptor (NgR) and LINGO-1 to activate
RhoA in response to myelin-based growth inhibitors
such as myelin-associated glycoprotein (MAG). In
this issue of Neuron, Domeniconi et al., in a surpris-
ing turn, show that MAG induces intramembrane pro-
teolysis (RIP) of p75NTR and find that p75NTR cleav-
age is required for MAG-induced RhoA activation and
growth inhibition.
The p75 neurotrophin receptor (p75NTR) has some-
thing for everyone. Since its identification and cloning
in the 1980s, this receptor has been implicated in di-
verse and often contradictory functions that include
promoting survival and inducing apoptosis, enhancing
neurite growth and facilitating growth cone collapse,
and mediating differentiation and enhancing prolifera-
tion. The recent identification of several cell surface
proteins that associate with p75NTR has helped explain
this dizzying complexity, because it has revealed that
p75NTR is a component of several discrete cell surface
signaling platforms that perform distinct functions.
One of the signaling platforms in which p75NTR par-
ticipates is a receptor complex that mediates growth
inhibition in response to the myelin-based growth inhib-
itory proteins (MBGIs), Nogo, myelin-associated glyco-
protein (MAG), and oligodendrocyte-myelin glycopro-
tein (OMgp). Along with p75NTR, the components of
the MBGI receptor complex are the Nogo receptor, a
GPI-linked protein that binds the MBGIs (Fournier et
al., 2001), and LINGO-1, a single-pass transmembrane
protein whose function remains unclear (Mi et al., 2004).
Studies from several labs have demonstrated that
p75NTR plays a key role in mediating the RhoA activa-
tion that is required for growth inhibition, but mecha-
nistic details have been lacking (Dubreuil et al., 2003;
Yamashita and Tohyama, 2003).
In this issue of Neuron, Marco Domeniconi and col-
leagues show that treatment of postnatal cerebellar
granule neurons (CGNs) with MAG results in cleavage
of p75NTR and production of a 25 kDa intracellular
fragment. The authors show that MAG induces a two-
step proteolysis of the receptor; the first cleavage is
initiated by α-secretase and generates a 30 kDa inter-
mediate, which is subsequently cleaved by γ-secretase
to generate a final 25 kDa product. Domeniconi et al.
(2005) go on to show that chimeric forms of p75NTR
that are resistant to cleavage by α- or γ-secretase act
as dominant-negatives that block MAG-induced growth
inhibition when expressed in NG108 cells and in DRG
sensory neurons. Importantly, inhibitors of α- and
γ-secretase are shown to block MAG-induced growth
inhibition and RhoA activation on CGNs in vitro, raising
the possibility that blocking secretase activity may fa-
cilitate neuronal regrowth and functional recovery.
These data add exciting new insights into MBGI ac-tion and p75NTR signaling mechanisms and, of course,
raise many new questions. Perhaps most importantly,
how does MAG binding to NgR induce p75NTR cleav-
age? Several previous studies have shown that cleav-
age of p75NTR by α-secretase can be induced by addi-
tion of phorbol esters and activation of protein kinase
C (Jung et al., 2003; Kanning et al., 2003). However,
Domeniconi et al. (2005) found that PKC inhibition has
no effect on α-secretase processing of p75NTR but in-
stead blocks the receptor’s γ-secretase cleavage. This
finding is particularly interesting in light of earlier recent
work by Sivasankaran et al. (2004), who showed that
PKC activation induced by MAG and Nogo is required
for RhoA activation and growth inhibition induced by
MBGIs in CGNs (Sivasankaran et al., 2004). Importantly,
this group also reported that MAG-induced PKC activa-
tion was blocked by a dominant-negative form of NgR
and by a truncated form of p75NTR lacking its intracel-
lular domain. Taken together, a plausible model that
emerges is that MAG binding to the NgR receptor in-
duces a conformational change in the MBGI receptor
complex that may expose an α-secretase cleavage site
in p75NTR. After this initial constitutive proteolysis oc-
curs, the truncated transmembrane fragment of p75NTR
becomes a suitable substrate for γ-secretase cleavage,
which may be activated through a PKC-dependent pro-
cess that lies downstream of NgR and p75NTR (Figure
1). In this scheme, it is conceivable that LINGO-1 could
facilitate α-secretase-induced p75NTR cleavage in re-
sponse to MBGIs, either by altering p75NTR conforma-
tion or by recruiting the secretase, or it could facilitate
PKC activation in response to MBGIs.
Understanding how γ-secretase cleavage of p75NTR
results in RhoA activation is another important issue.
Previous studies have established that p75NTR binds
directly to Rho-GDI, a RhoA inhibitor, and have shown
that p75NTR disrupts the RhoA:Rho-GDI complex (Ya-
mashita and Tohyama, 2003). Domeniconi et al. (2005)
suggest that the γ-secretase cleavage product of
p75NTR may facilitate the release of RhoA from Rho-
GDI more efficiently than the full-length receptor, and it
will be interesting to test this experimentally in future
studies. It is, of course, likely that the devil is in the
details here, and it will be important to determine if
other cytosolic p75NTR interactors identified to date
play a role in this process, whether additional post-
translation modifications of the receptor are important,
and whether localization of the receptor fragment to a
precise compartment, such as lipid rafts, is required for
RhoA activation. It is interesting that earlier work by
Kanning et al. (2003) and repeated here by Domeniconi
et al. (2005) shows that the γ-secretase cleavage prod-
uct is rapidly degraded and is only detected in cells
treated with proteosomal inhibitors; it is possible that
this may be a mechanism that acts to spatially restrict
the action of this fragment, which, given its rapid turn-
over, must be a very potent RhoA activator. It is also
worth noting that a p75 intracellular fragment that has
been previously used as a constitutive activator of
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JIt is important to consider whether RIP is a general
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mechanism necessary for activating RhoA by receptors B
of this class. TROY, a TNFR superfamily member, has K
recently been shown to participate as a functional ho- a
molog for p75NTR in some neuronal populations (Park M
et al., 2005; Shao et al., 2005), and it seem likely that S
Pthis receptor may undergo similar cleavage events that
are required for activity. M
AIn sum, the paper by Domeniconi et al. (2005) opens a
2new chapter on the proximal receptor-based signaling
Pevents that regulate neurite growth inhibition. Although
Kp75NTR cleavage events have been well described in
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place them in a physiological context. The study identi- (
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the actions of the MBGIs and, together with work of X
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PKC activity in this process. These are exciting findings
Dthat will have a major impact on the field. Given the
breakneck pace at which work in this field is proceed-
ing, we predict rapid progress in this area and a quick
resolution to many of the interesting questions raised
by this work.
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